DMW - Deutsche Medizinische Wochenschrift, Table of Contents Dtsch Med Wochenschr 2010; 135(10): 461-465DOI: 10.1055/s-0030-1249188 Aktuelle Diagnostik & Therapie | Review articlePneumologie© Georg Thieme Verlag KG Stuttgart · New YorkSeltene zystische Lungenerkrankungen: Lymphangioleiomyomatose, pulmonale Langerhanszell-Histiozytose, lymphozytäre interstitielle PneumonieRare cystic lung diseases: lymphangioleiomyomatosis, pulmonary langerhans’ cell histiocytosis and lymphocytic interstitial pneumoniaA. Prasse1 , G. Kayser2 1Abteilung für Pneumologie, Universitätsklinikum Freiburg, 2Institut für Pathologie, Universitätsklinikum Freiburg Recommend Article Abstract Buy Article Schlüsselwörter zystische Lungenerkrankungen - interstitielle Lungenerkrankungen - Lymphangioleimyomatose - pulmonale Langerhanszell-Histiozytose - lymphozytäre interstitielle Pneumonie Keywords diffuse parenchmal lung disease - lymphangioleiomyomatosis - pulmonary langerhans’ cell histiocytosis - lymphocytic interstitial pneumonia Full Text References Literatur 1 Antoniou K M, Margaritopoulos G, Economidou F, Siafakas N M. Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement. Eur Respir J. 2009; 33 882-896 2 Attili A K, Kazerooni E A, Gross B H, Flaherty K R, Myers J L, Martinez F J. Smoking-related interstitial lung disease: radiologic – clinical – pathologic correlation. Radiographics. 2008; 28 1383-1396 3 Clements D, Mayer R J, Johnson S R. Subcellular distribution of the TSC2 gene product tuberin in human airway smooth muscle cells is driven by multiple localization sequences and is cell-cycle dependent. Am J Physiol Lung Cell Mol Physiol. 2007; 292 L258-266 4 Cosgrove G P, Frankel S K, Brown K K. Challenges in pulmonary fibrosis. 3: Cystic lung disease. Thorax. 2007; 62 820-829 5 Dauriat G, Mal H, Thabut G. et al . Lung transplantation for pulmonary langerhans’ cell histiocytosis: a multicenter analysis. Transplantation. 2006; 81 746-750 6 Davies D M, Johnson S R, Tattersfield A E. et al . Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis. Engl J Med. 2008; 358 200-203 7 El-Chemaly S, Taveira-DaSilva A, Stylianou M P, Moss J. Statins in lymphangioleiomyomatosis: a word of caution. Eur Respir J. 2009; 34 513-514 8 Galvin J R, Franks T J. Smoking-related lung disease. J Thorac Imaging. 2009; 24 274-284 9 Grant L A, Babar J, Griffin N. Cysts, cavities, and honeycombing in multisystem disorders: differential diagnosis and findings on thin-section CT. Clin Radiol. 2009; 64 439-448 10 Johnson S R. Lymphangioleiomyomatosis. Eur Respir J. 2006; 27 1056-1065 11 Kim E A, Lee K S, Johkoh T, Kim T S, Suh G Y, Kwon O J, Han J. Interstitial lung diseases associated with collagen vascular diseases: radiologic and histopathologic findings. Radiographics. 2002; 22 S151-S165 12 Papiris S A, Tsonis I A, Moutsopoulos H M. Sjögren’s Syndrome. Semin Respir Crit Care Med. 2007; 28 459-471 13 Prasse A, Stahl M, Schulz G. et al . Essential role of osteopontin in smoking-related interstitial lung diseases. Am J Pathol. 2009; 174 1683-1691 14 Vassallo R, Ryu J H. Tobacco smoke-related diffuse lung diseases. Semin Respir Crit Care Med. 2008; 29 643-650 15 Visscher D W, Myers J L. Bronchiolitis: the pathologist’s perspective. Proc Am Thorac Soc. 2006; 3 41-47 16 Watz H, Oltmanns A, Kimmel S, Magnussen H, Wirtz H, Kirsten D. Sporadische Lymphangioleiomyomatose. Klinische und lungenfunkionelle Charakterisierung von 32 Patientinnen. Dtsch Med Wochenschr. 2008; 133 705-708 PD Dr. Antje Prasse Abteilung für Pneumologie, Universitätsklinikum Freiburg Killianstr. 5 79106 Freiburg Email: antje.prasse@uniklinik-freiburg.de